Ascendis Pharma A/S Cash Flows From Used In Financing Activities
Ascendis Pharma A/S (ASND) reported Cash Flows From Used In Financing Activities of EUR 36.33 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:CashFlowsFromUsedInFinancingActivities · last filed 2026-02-11
- Ascendis Pharma A/S cash flows from used in financing activities for the quarter ending 2025-12-31 was 8.52M EUR, a 9689.66% increase year-over-year.
- Ascendis Pharma A/S cash flows from used in financing activities for the quarter ending 2025-09-30 was 38.85M EUR, a 90.92% decline year-over-year.
- Ascendis Pharma A/S cash flows from used in financing activities for the quarter ending 2025-06-30 was 6.98M EUR.
- Ascendis Pharma A/S cash flows from used in financing activities for the quarter ending 2025-03-31 was -18.02M EUR, a 197.83% decline year-over-year.
| Period end | Cash Flows From Used In Financing Activities 3 month | Cash Flows From Used In Financing Activities 6 month | Cash Flows From Used In Financing Activities 9 month | Cash Flows From Used In Financing Activities 12 month |
|---|---|---|---|---|
| 2025-12-31 | 8.52M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 47.37M EUR derived: sum of 2 quarters · filed 2026-02-11 | 54.35M EUR derived: sum of 3 quarters · filed 2026-02-11 | 36.33M EUR 20-F · filed 2026-02-11 |
| 2025-09-30 | 38.85M EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | 45.84M EUR derived: sum of 2 quarters · filed 2025-11-12 | 27.81M EUR 6-K · filed 2025-11-12 | 27.90M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-06-30 | 6.98M EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-08-07 | -11.04M EUR 6-K · filed 2025-08-07 | -10.96M EUR derived: sum of 3 quarters · filed 2026-02-11 | 416.92M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2025-03-31 | -18.02M EUR 6-K · filed 2025-05-01 | -17.94M EUR derived: sum of 2 quarters · filed 2026-02-11 | 409.94M EUR derived: sum of 3 quarters · filed 2026-02-11 | 407.48M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-12-31 | 87.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 427.96M EUR derived: sum of 2 quarters · filed 2026-02-11 | 425.51M EUR derived: sum of 3 quarters · filed 2026-02-11 | 443.93M EUR 20-F · filed 2026-02-11 |
| 2024-09-30 | 427.87M EUR derived: 6-K 9 month − 6-K 6 month · filed 2025-11-12 | 425.42M EUR derived: sum of 2 quarters · filed 2025-11-12 | 443.84M EUR 6-K · filed 2025-11-12 | 437.79M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | -2.46M EUR derived: 6-K 6 month − 6-K 3 month · filed 2025-08-07 | 15.97M EUR 6-K · filed 2025-08-07 | 9.91M EUR derived: sum of 3 quarters · filed 2026-02-11 | 153.27M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | 18.42M EUR 6-K · filed 2025-05-01 | 12.37M EUR derived: sum of 2 quarters · filed 2026-02-11 | 155.73M EUR derived: sum of 3 quarters · filed 2026-02-11 | 153.42M EUR derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | -6.05M EUR derived: 20-F 12 month − 6-K 9 month · filed 2026-02-11 | 137.30M EUR derived: sum of 2 quarters · filed 2026-02-11 | 134.99M EUR derived: sum of 3 quarters · filed 2026-02-11 | 134.29M EUR 20-F · filed 2026-02-11 |
| 2023-09-30 | 143.36M EUR derived: 6-K 9 month − 6-K 6 month · filed 2024-11-14 | 141.05M EUR derived: sum of 2 quarters · filed 2024-11-14 | 140.35M EUR 6-K · filed 2024-11-14 | 141.70M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-06-30 | -2.31M EUR derived: 6-K 6 month − 6-K 3 month · filed 2024-09-03 | -3.01M EUR 6-K · filed 2024-09-03 | -1.66M EUR derived: sum of 3 quarters · filed 2025-02-12 | -1.74M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-03-31 | -702.00K EUR 6-K · filed 2024-05-02 | 647.00K EUR derived: sum of 2 quarters · filed 2025-02-12 | 571.00K EUR derived: sum of 3 quarters · filed 2025-02-12 | -1.66M EUR derived: sum of 4 quarters · filed 2025-02-12 |
| 2022-12-31 | 1.35M EUR derived: 20-F 12 month − 6-K 9 month · filed 2025-02-12 | 1.27M EUR derived: sum of 2 quarters · filed 2025-02-12 | -962.00K EUR derived: sum of 3 quarters · filed 2025-02-12 | 396.77M EUR 20-F · filed 2025-02-12 |
| 2022-09-30 | -76.00K EUR derived: 6-K 9 month − 6-K 6 month · filed 2023-11-07 | -2.31M EUR derived: sum of 2 quarters · filed 2023-11-07 | 395.42M EUR 6-K · filed 2023-11-07 | 374.80M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-06-30 | -2.23M EUR derived: 6-K 6 month − 6-K 3 month · filed 2023-09-05 | 395.50M EUR 6-K · filed 2023-09-05 | 374.87M EUR derived: sum of 3 quarters · filed 2024-02-07 | 745.48M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-03-31 | 397.74M EUR 6-K · filed 2023-04-27 | 377.11M EUR derived: sum of 2 quarters · filed 2024-02-07 | 747.71M EUR derived: sum of 3 quarters · filed 2024-02-07 | 749.10M EUR derived: sum of 4 quarters · filed 2024-02-07 |
| 2021-12-31 | -20.63M EUR derived: 20-F 12 month − 6-K 9 month · filed 2024-02-07 | 349.98M EUR derived: sum of 2 quarters · filed 2024-02-07 | 351.37M EUR derived: sum of 3 quarters · filed 2024-02-07 | 351.39M EUR 20-F · filed 2024-02-07 |
| 2021-09-30 | 370.61M EUR derived: 6-K 9 month − 6-K 6 month · filed 2022-11-02 | 372.00M EUR derived: sum of 2 quarters · filed 2022-11-02 | 372.02M EUR 6-K · filed 2022-11-02 | 382.33M EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | 1.39M EUR derived: 6-K 6 month − 6-K 3 month · filed 2022-08-10 | 1.41M EUR 6-K · filed 2022-08-10 | 11.72M EUR derived: sum of 3 quarters · filed 2023-02-16 | 596.39M EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | 20.00K EUR 6-K · filed 2022-05-11 | 10.33M EUR derived: sum of 2 quarters · filed 2023-02-16 | 595.00M EUR derived: sum of 3 quarters · filed 2023-02-16 | 603.79M EUR derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | 10.31M EUR derived: 20-F 12 month − 6-K 9 month · filed 2023-02-16 | 594.98M EUR derived: sum of 2 quarters · filed 2023-02-16 | 603.77M EUR derived: sum of 3 quarters · filed 2023-02-16 | 602.65M EUR 20-F · filed 2023-02-16 |
| 2020-09-30 | 584.67M EUR derived: 6-K 9 month − 6-K 6 month · filed 2021-11-10 | 593.45M EUR derived: sum of 2 quarters · filed 2021-11-10 | 592.34M EUR 6-K · filed 2021-11-10 | 596.60M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2020-06-30 | 8.79M EUR derived: 6-K 6 month − 6-K 3 month · filed 2021-08-27 | 7.67M EUR 6-K · filed 2021-08-27 | 11.93M EUR derived: sum of 3 quarters · filed 2022-03-02 | 14.06M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2020-03-31 | -1.12M EUR 6-K · filed 2021-05-27 | 3.15M EUR derived: sum of 2 quarters · filed 2022-03-02 | 5.27M EUR derived: sum of 3 quarters · filed 2022-03-02 | 13.41M EUR derived: sum of 4 quarters · filed 2022-03-02 |
| 2019-12-31 | 4.26M EUR derived: 20-F 12 month − 6-K 9 month · filed 2022-03-02 | 6.39M EUR derived: sum of 2 quarters · filed 2022-03-02 | 14.53M EUR derived: sum of 3 quarters · filed 2022-03-02 | 493.59M EUR 20-F · filed 2022-03-02 |
| 2019-09-30 | 2.12M EUR derived: 6-K 9 month − 6-K 6 month · filed 2020-11-12 | 10.26M EUR derived: sum of 2 quarters · filed 2020-11-12 | 489.33M EUR 6-K · filed 2020-11-12 | 490.25M EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-06-30 | 8.14M EUR derived: 6-K 6 month − 6-K 3 month · filed 2020-08-27 | 487.21M EUR 6-K · filed 2020-08-27 | 488.13M EUR derived: sum of 3 quarters · filed 2021-03-10 | 490.20M EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2019-03-31 | 479.07M EUR 6-K · filed 2020-05-19 | 479.99M EUR derived: sum of 2 quarters · filed 2021-03-10 | 482.06M EUR derived: sum of 3 quarters · filed 2021-03-10 | 485.43M EUR derived: sum of 4 quarters · filed 2021-03-10 |
| 2018-12-31 | 925.00K EUR derived: 20-F 12 month − 6-K 9 month · filed 2021-03-10 | 3.00M EUR derived: sum of 2 quarters · filed 2021-03-10 | 6.36M EUR derived: sum of 3 quarters · filed 2021-03-10 | 203.27M EUR 20-F · filed 2021-03-10 |
| 2018-09-30 | 2.07M EUR derived: 6-K 9 month − 6-K 6 month · filed 2019-11-18 | 5.43M EUR derived: sum of 2 quarters · filed 2019-11-18 | 202.34M EUR 6-K · filed 2019-11-18 | 218.77M EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-06-30 | 3.37M EUR derived: 6-K 6 month − 6-K 3 month · filed 2019-08-28 | 200.27M EUR 6-K · filed 2019-08-28 | 216.70M EUR derived: sum of 3 quarters · filed 2020-04-03 | 324.35M EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2018-03-31 | 196.91M EUR 6-K · filed 2019-05-30 | 213.33M EUR derived: sum of 2 quarters · filed 2020-04-03 | 320.98M EUR derived: sum of 3 quarters · filed 2020-04-03 | 320.98M EUR derived: sum of 4 quarters · filed 2020-04-03 |
| 2017-12-31 | 16.43M EUR derived: 20-F 12 month − 6-K 9 month · filed 2020-04-03 | 124.08M EUR derived: sum of 2 quarters · filed 2020-04-03 | 124.08M EUR derived: sum of 3 quarters · filed 2020-04-03 | 124.72M EUR 20-F · filed 2020-04-03 |
| 2017-09-30 | 107.65M EUR derived: 6-K 9 month − 6-K 6 month · filed 2018-11-28 | 107.65M EUR derived: sum of 2 quarters · filed 2018-11-28 | 108.30M EUR 6-K · filed 2018-11-28 | |
| 2017-06-30 | 0.00 EUR derived: 6-K 6 month − 6-K 3 month · filed 2018-08-29 | 644.00K EUR 6-K · filed 2018-08-29 | ||
| 2017-03-31 | 644.00K EUR 6-K · filed 2018-05-30 | |||
| 2016-12-31 | 117.46M EUR 20-F · filed 2019-04-03 | |||
| 2015-12-31 | 105.74M EUR 20-F · filed 2018-03-28 |